|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Interest earned on investments held in Trust Account | |
| Deferred advisory fee payable | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Long-term prepaid insurance | |
| Accrued expenses | |
| Net cash used in operating activities | |
| Cash flows from investing activities: | |
| Investment of cash in trust account | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Proceeds from sale of Units | |
| Underwriting discount paid | |
| Proceeds from sale of Private Placement Warrants | |
| Proceeds from related party loan | |
| Payment of offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash beginning of period | |
| Cash end of period | |
| Supplemental disclosure of non-cash investing and financing activities: | |
| Deferred legal fee payable | |
| Deferred underwriting fee payable |
Loading...
